The relationship of genetic risk factors with the development of arterial hypertension taking into account ethnic differences

Aim. To study the influence of genetic factors on the risk of essential arterial hypertension (AH) and the course in patients of Russian and Buryat ethnicity.

Material and methods. The study included 248 patients of the Russian and 92 patients of the Buryat ethnic group. All patients were evaluated for genotypes by ACE, ADRB1, ADRB2, ADRB3, CAT, NOS3, CYP11B2, AGT, STK39, EDN1, GNB3 markers. Following clinical data were determined: age, body mass index, smoking history, stage and degree of AH, the presence and nature of target organ damage, hereditary history. In the study, patients of the two ethnic groups were divided into the case and control groups depending on the presence or absence of AH.

Results. In patients of the Russian ethnic group, an association of a more severe AH course with a burdened family history was revealed, in contrast to patients of Buryat nationality. In the Buryat group, the development of AH is associated with polymorphisms of the candidate genes ADRB3 (rs4994), GNB3 (rs5443), ACE (rs464994), STK39 (rs3754777), EDN1 (rs9349379). In the Russian group, ACE, EDN1, CYP11B2 (rs 1799998), GNB3, NOS3 (rs1799983), ADRB1 (rs1801253) genes had a significant contribution. When comparing the assortment of allele frequency of the ACE gene polymorphic marker among two ethnic groups, the “I” allele was found significantly more frequently in patients of Russian group.

Conclusion. The results of the study revealed ethnic differences in the genetic features of essential AH. For the first time, an association between genetic markers encoding elements of the renin-angiotensin system, sympathoadrenal system, endothelial system and AH risk in patients of Buryat nationality was established. The identification of ethnic differences and genetic predisposition to AH, makes it possible to understand the role of the hereditary component of hypertension. We suppose that these data in conjunction with the influence of the environment, can help to develop one of the areas of personalized medicine.

1. Rapsomaniki E, Timmis A, George Ju, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specifi c associations in 125 million people. The Lancet. 2014;383(9932):1899-911. doi:10.1016/S0140-6736(14)60685-1.

2. Ehret GB. Genome-Wide Association Studies: Contribution of Genomics to Understanding Blood Pressure and Essential Hypertension. Current Hypertension Reports. 2010;12(1):17-25. doi:10.1007/s11906-009-0086-6.

3. Cornelissen VA, Fagard RH, Coeckelberghs E, et al. Impact of Resistance Training on Blood Pressure and Other Cardiovascular Risk Factors A Meta-Analysis of Randomized, Controlled Trials. Hypertension. 2011;58(5):950-8. doi:10.1161/HYPERTENSIONAHA.111.177071.

4. Tang H, Quertermous T, Rodriguez B. Genetic Structure, Self-Identified Race/Ethnicity, and Confounding in Case-Control Association Studies. American Journal of Human Genetics. 2005;(76):268-75. doi:10.1086/427888.

5. Ying CQ, Wang YH, Wu ZL, et al. Association of the renin gene polymorphism, three angiotensinogen gene polymorphisms and the haplotypes with essential hypertension in the Mongolian population. Clin Exp Hypertens. 2010;32(5) :293-300. doi:10.3109/10641960903443517.

6. Tolstikova TG, Sorokina IV, Brisgalov AO, et al. The use of a new approach to prevention and therapy of acute arterial hypertension with complex of well-known drugs with vegetable glycosides. Rational Pharmacother. Card. 2006;1:55-8 (In Russ.)

7. Coelho SC, Berillo O, Ouerd S, et al. Three-month endothelial human endothelin-1 overexpression causes blood pressure elevation and vascular and kidney injury. Hypertension. 2018;71:208-16. doi:10.1161/HYPERTENSIONAHA.117.09925.

8. Kabanina VA, Kononenko EK, Bulgakova OA, et al. Promotor polymorphism — 262C/T of catalase gene and risk of essential hypertension in Russian inhabitants of Kursk region. Vestnik RGMU. 2010;2:495-6. (In Russ.)

9. Mansego ML, Solar GM, Alonso MP, et al. Polymorphisms of antioxidant enzymes, blood pressure and risk of hypertension. Hypertens. 2011;29(3):492-500. doi:10.1097/HJH.0b013e328341f1b2.

10. Ershova OA, Bairova TA. Polymorphism -262c/t of catalase gene (rs1001179) in russian and buryat populations with essential hypertension living in the eastern siberia, 2015, 3 (103). (In Russ.)

11. Yang H, Ye L, Wang Q, Cai D, et al. A meta-analytical assessment of STK39 three well-defined polymorphisms in susceptibility to hypertension. Sci Rep. 2016 May 4;6:25290. doi:10.1038/srep25290.

12. Nikolayeva AA, Nikolayev KYu, Li fs hits GI, Popova LV. Vascular reactivity in coronary atherosclerosis and socially significant risk factors (smoking and alcohol). State Public Scientific Technological Library of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk, 2011. (In Russ.) ISBN: 978-5-94560-149-9

13. Li YY, Lu XZ, Wang H, et al. ADRB3 Gene Trp64Arg Polymorphism and Essential Hypertension: A Meta-Analysis Including 9,555 Subjects. Front Genet. 2018 Apr 4;9:106. doi:10.3389/fgene.2018.00106